Research Index
Protegrin-1 Research Index
PSI surfaces 29 peer-reviewed studies on Protegrin-1, prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
29 studies
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
Coutinho LFD, DE Oliveira Neves LF, Camilo RP
J Sports Med Phys Fitness·2026·Animal·PubMed →
Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Uçaktürk E, Nemutlu E
J Pharm Biomed Anal·2026·Animal·GH Activity·PubMed →
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Mavrych V, Shypilova I, Bolgova O
Front Aging·2026·Review·PubMed →
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, Awan TM
Sports Med·2026·Review·PubMed →
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA
J Am Acad Orthop Surg Glob Res Rev·2026·Review·Wound Healing·PubMed →
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, Bolia IK, Feingold CL et al.
Am J Sports Med·2026·Review·PubMed →
Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.
Thomas A, Walpurgis K, Thevis M
J Mass Spectrom·2024·Animal·GH Activity·PubMed →
Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.
Cristea CD, Radu M, Toboc A et al.
Anal Biochem·2023·Animal·PubMed →
Probing for peptidic drugs (2-10 kDa) in doping control blood samples.
Thomas A, Thilmany S, Hofmann A et al.
Anal Sci Adv·2022·Animal·PubMed →
An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.
Coppieters G, Deventer K, Polet M et al.
J Pharm Biomed Anal·2022·Animal·GH Activity·PubMed →
Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.
Danila GM, Puiu M, Zamfir LG et al.
Talanta·2022·Animal·PubMed →
Advances in the detection of growth hormone releasing hormone synthetic analogs.
Memdouh S, Gavrilović I, Ng K et al.
Drug Test Anal·2021·Animal·GH Activity·PubMed →
Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.
Pont L, Alechaga É, Terrero A et al.
J Chromatogr A·2020·Animal·GH Activity·PubMed →
A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.
Timms M, Ganio K, Steel R
Drug Test Anal·2019·Animal·GH Activity·PubMed →
An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.
Timms M, Ganio K, Forbes G et al.
Drug Test Anal·2019·Animal·GH Activity·PubMed →
The study of doping market: How to produce intelligence from Internet forums.
Pineau T, Schopfer A, Grossrieder L et al.
Forensic Sci Int·2016·Animal·PubMed →
Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.
Knoop A, Thomas A, Fichant E et al.
Anal Bioanal Chem·2016·Animal·GH Activity·PubMed →
Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.
Van Hout MC, Hearne E
Subst Use Misuse·2016·Review·GH Activity·PubMed →
Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.
Thomas A, Walpurgis K, Tretzel L et al.
Drug Test Anal·2015·Animal·PubMed →
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.
Thevis M, Thomas A, Schänzer W
Expert Rev Proteomics·2014·Animal·PubMed →
Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Kwok WH, Ho EN, Lau MY et al.
Anal Bioanal Chem·2013·Animal·PubMed →
Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
Thomas A, Schänzer W, Delahaut P et al.
Methods·2012·Review·GH Activity·PubMed →
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
Henninge J, Pepaj M, Hullstein I et al.
Drug Test Anal·2010·Animal·GH Activity·PubMed →
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
Sackmann-Sala L, Ding J, Frohman LA et al.
Growth Horm IGF Res·2009·Animal·GH Activity·PubMed →
Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth.
Gautam D, Jeon J, Starost MF et al.
Proc Natl Acad Sci U S A·2009·Animal·Weight Loss, GH Activity·PubMed →
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
Ionescu M, Frohman LA
J Clin Endocrinol Metab·2006·Human·GH Activity·PubMed →
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Teichman SL, Neale A, Lawrence B et al.
J Clin Endocrinol Metab·2006·Human·GH Activity·PubMed →
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.
Alba M, Fintini D, Sagazio A et al.
Am J Physiol Endocrinol Metab·2006·Animal·Longevity, Weight Loss, GH Activity·PubMed →
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.
Jetté L, Léger R, Thibaudeau K et al.
Endocrinology·2005·Animal·GH Activity·PubMed →